NE
Healthcare & Life Sciences

Neowisebio

Neowisebio is a Healthcare & Life Sciences startup based in China, most recent round Series A.

Activeseries-a
series-a
Stage

About Neowisebio

Neowisebio is a company headquartered in China. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences.

Neowisebio develops TCR-T immunotherapy drugs for solid tumor patients by utilizing a highly sensitive target-TCR discovery and validation platform, aiming to expand treatment targets and options for cancer patients.

Explore Neowisebio's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in China